The shift to AI diagnostics China’s medical landscape is rapidly evolving by integrating AI tools into daily clinical routines. The focus is specifically on using technology to tackle pancreatic cancer—a silent disease that often goes undetected until it is too late for effective treatment.
Technical approach and clinical findings Clinicians are testing an AI system known as PANDA to scan non-contrast CT images. This method is particularly significant because it leverages standard medical scans that are already available, avoiding additional radiation or costs for the patient.
-
Scope: The AI screened over 180,000 existing CT scans.
-
Success rate: About 20 cases were identified, half of which were still in the early, treatable stages.
-
Impact: The system acts as a “safety net,” catching malignancies in patients who initially visited the hospital for unrelated, minor symptoms.
Operational and ethical hurdles Despite the high accuracy in identifying lesions, several issues have emerged during the trial:
-
False alarms: A high number of false positives can lead to unnecessary medical procedures and patient anxiety.
-
Resource constraints: Current hospital infrastructure and staffing levels struggle to keep up with the volume of data and follow-up appointments required by AI alerts.
-
Patient skepticism: Diagnosing a life-threatening illness before symptoms appear sometimes leads to distrust, with patients questioning the necessity of further expensive tests.
Source: https://tuoitre.vn/trung-quoc-quyet-liet-dua-ai-vao-chan-doan-benh-nhung-cau-hoi-dat-ra-2026010219442022.htm